Evaluation of the effectiveness of hormone therapy in patients with premature ovarian insufficiency

Objective. Evaluation of the effectiveness of the effect of various hormone therapy regimens on the severity of clinical symptoms in patients with premature ovarian insufficiency. Materials and methods. A prospective opened scientific study was conducted involving 56 patients with premature ovarian insufficiency. The general cohort was divided into two groups depending on the reproductive plans of the patients. Group 1 included 31 patients who received hormone replacement therapy aimed to preserve ovarian function with the possible subsequent onset of pregnancy. The 2nd group included 25 patients who had no reproductive plans and were prescribed a combined oral contraceptive. All patients underwent a thorough clinical and laboratory examination, paying attention to the collection of family anamnesis, a clinical assessment of the severity of menopausal syndrome on the Green scale, and the results of hormonal studies. Ultrasound examination of the pelvic organs was performed 2, 6, and 12 months after the start of hormonal therapy. Mathematical methods included statistical analysis carried out using Microsoft Office 2007 and Excel 2007 licensed application programs. Results. After 12 months of hormone therapy, both groups showed a statistically significant decrease in the severity of such symptoms of estrogen deficiency as sweating and genitourinary menopausal syndrome. In group 2 patients, a statistically significant decrease in the frequency of episodes of insomnia and hot flashes was also achieved. The severity of the remaining symptoms of estrogen deficiency decreased by 2 times when calculated on the Green scale and amounted to 10—11 points, which was regarded as a mild degree of estrogen deficiency. An analysis of the condition of patients in both groups showed that the use of both hormone replacement therapy and a combined oral contraceptive in women with premature ovarian insufficiency helps preserve their physical and mental health and prevent complications associated with estrogen deficiency. Conclusion. Patients with premature ovarian insufficiency need a special approach and therapy depending on their reproductive plans. Early detection of latent and clinically pronounced forms of premature ovarian insufficiency helps the doctor to develop an algorithm for managing patients with this pathology in order to prevent age-related diseases. Patients of both groups showed high compliance and clinical effectiveness of the therapy, which contributes to improving the quality of life.